- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03827252
Respiratory Stability and Vegetative Coupling During Neonatal Skin-to-skin Care (PO-A-PO-PREMA)
May 9, 2023 updated by: Centre Hospitalier Universitaire, Amiens
Identification of Respiratory Stability Mechanisms During Skin-to-skin Care in Premature Infants in the Neonatal Intensive Care Unit: Infant-parent Vegetative Functions Coupling
The main purpose of this study is to identify and to determine the involvement of cardio-respiratory coordination mechanisms during SSC between the preterm infant and his (her) parent.
Study Overview
Status
Completed
Conditions
Detailed Description
The skin to skin care (SSC) is a technique that proceeds by laying the neonate ventrally on the parent's chest.
Many positive effects are recognized as due to SSC i.e, maintaining the infant's body temperature, better sleep organization, neurocognitive development and cardio-respiratory stability, more strength in parent-infant affective relations, reduction in neonatal and parental stress, more success in feeding with breast milk.
Nowadays, SSC is generalized in modern Neonatal Intensive Care Units as part of developmental care.
However, the mechanisms involved in SSC are not totally understood.
The hypothesis in this study is that the cardio-respiratory stability results partially from the intervention of the coordination between cardiac and respiratory activities.
These suppose the involvement of complex mechanisms of cardio-respiratory coordination including neuro-autonomous loops with chemoreceptors and baroreceptors, bulbar vasomotor and respiratory regulatory centers, ortho-parasympathetic neuronal and chemical pathways and cardiac, vascular and lung effectors.
In this study the identification of these characteristics will be performed by processing signals of ECG, SaO2 (arterial oxygen saturation), respiratory movements, perfusion index, cutaneous and ambient temperature extracted from the clinical monitoring systems.
Each preterm infant included in the study will be explored twice, 5-10 days apart.
The explorations will be carried out on 3 steps: before (at least 30 minutes), during (at least 60 minutes) and after (≥ 60 minutes) the SSC session.
Each patient will participate in the study for 10 days at maximum.
Inclusions in the study will last for a total period of 18 months and 10 days.
The cardio-respiratory coordination will be assessed using coordigram technique, corresponding to the proportion of time with > 0.7 amplitude on spectral density.
Study Type
Observational
Enrollment (Actual)
44
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sabrina GOUDJIL, Ph
- Phone Number: +33 0322087741
- Email: goudjil.sabrina@chu-amiens.fr
Study Locations
-
-
-
Amiens, France, 80000
- CHU Amiens-Picardie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 8 months (Child)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Premature infant from 28weeks + 0 day to 36 weeks + 6 days gestational corrected age
Description
Inclusion Criteria:
- Premature infant from 28weeks + 0 day to 36 weeks + 6 days gestational corrected age
- At least 72 hours postnatal age
- Benefiting skin-to-skin care
Exclusion Criteria:
- Severe congenital malformation and nervous system dysfunction (e.g., Ondine Sd)
- Septic shock
- Mechanical ventilation support
- Severe pulmonary arterial hypertension
- Analgesia morphinics at high dosage and curare
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardio-respiratory coordination index
Time Frame: 10 days
|
Percentage of time during the recording that fulfills the criteria of coordination ( > 0.7 amplitude of spectra in coordigram)
|
10 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cardio-respiratory coordination index by phase analysis technique
Time Frame: 10 days
|
10 days
|
Correlation between cardio-respiratory coordination index and SaO2
Time Frame: 10 days
|
10 days
|
Correlation of temperatures (infant, parent) and cardio-respiratory coordination index
Time Frame: 10 days
|
10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 7, 2018
Primary Completion (Actual)
December 11, 2019
Study Completion (Actual)
September 12, 2020
Study Registration Dates
First Submitted
January 31, 2019
First Submitted That Met QC Criteria
January 31, 2019
First Posted (Actual)
February 1, 2019
Study Record Updates
Last Update Posted (Actual)
May 10, 2023
Last Update Submitted That Met QC Criteria
May 9, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2017_843_0008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Infant
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
Istituto Giannina GasliniEubrainRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
-
Christiana Care Health ServicesCompletedInfant | Infant, Premature | Infant, Preterm | Infant, LateUnited States